# Efavirenz (EFV) Intensification

> **NCT07193875** · PHASE4 · COMPLETED · sponsor: **Washington University School of Medicine** · enrollment: 7 (actual)

## Conditions studied

- HIV

## Interventions

- **DRUG:** Efavirenz 600mg

## Key facts

- **NCT ID:** NCT07193875
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-09
- **Primary completion:** 2024-12-16
- **Final completion:** 2024-12-16
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2025-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07193875

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07193875, "Efavirenz (EFV) Intensification". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07193875. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*